As many of you know, the 2022 ACA meeting will be held in Portland, OR on July 
29 to August 2. I would like to draw your attention to the session on 
fragment-based drug discovery and invite you to submit an abstract for an oral 
presentation. We welcome contributions from students as well as PIs. The 
Abstract deadline is April 15.

https://www.acameeting.com/

Session details:

3.2.2 Fragment Based Drug Discovery
8/1/2022 @ 2:00:00 PM - 5:00:00 PM
Sponsoring SIG(s): Industrial
Co-Sponsoring SIG(s): BioMac
Session Chair(s): Matt Clifton, Jack Tanner
Fragment Based Drug Discovery (FBDD) utilizes small molecule compounds to help 
identify starting points in the drug discovery process. This process allowed 
for the discovery of lead compounds for difficult protein targets with 
small/shallow pockets or protein-protein interactions. In contrast to other 
screening techniques such as High-Throughput Screening (HTS) or DNA-encoded 
Libraries (DEL), FBDD utilizes small libraries of molecules (< 2000) with 
molecular weights less than ~200 Da. FBDD has been key in the development of 
multiple approved drugs and dozens of other drugs in clinical trials. This 
session will focus on the biophysical and structural techniques used in FBDD to 
identify initial starting points, optimization by fragment growing/linking, and 
the route to lead optimization.

--
John J. Tanner
Professor of Biochemistry and Chemistry
Associate Chair of Biochemistry
Department of Biochemistry
University of Missouri
117 Schweitzer Hall
503 S College Avenue
Columbia, MO 65211
Phone: 573-884-1280
Email: tanne...@missouri.edu<mailto:tanne...@missouri.edu>
https://cafnrfaculty.missouri.edu/tannerlab/
Lab: Schlundt Annex rooms 3,6,9, 203B, 203C
Office: Schlundt Annex 203A



########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1

This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list 
hosted by www.jiscmail.ac.uk, terms & conditions are available at 
https://www.jiscmail.ac.uk/policyandsecurity/

Reply via email to